Abstract | PURPOSE: Malignant rhabdoid tumors (MRT) have poor prognoses. Breast MRT is extremely rare; only three cases have been documented, with a mean prognosis of 7 months. Multi-agent chemotherapy with mastectomy and irradiation, as used in this case, may extend survival in breast MRT. PATIENT AND METHODS: RESULTS: The 19-month survival period of our case was almost three times that of reported breast MRT patients. CONCLUSION: Multi-agent chemotherapy combined with irradiation may be associated with the relatively long survival of the present case.
|
Authors | Yoshitaka Furuya, Hironobu Yanagie, Takashi Wakahara, Yoshiya Mishina, Harutoshi Akimoto, Le Minh Quang, Kenzo Hiroshima, Hiroshi Yasuhara |
Journal | Cancer chemotherapy and pharmacology
(Cancer Chemother Pharmacol)
Vol. 64
Issue 3
Pg. 623-7
(Aug 2009)
ISSN: 1432-0843 [Electronic] Germany |
PMID | 19322564
(Publication Type: Case Reports, Journal Article)
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Breast Neoplasms
(physiopathology, therapy)
- Chemotherapy, Adjuvant
(methods)
- Combined Modality Therapy
- Female
- Follow-Up Studies
- Humans
- Mastectomy
- Neoplasm Metastasis
- Rhabdoid Tumor
(physiopathology, therapy)
- Survival Rate
|